8-K Filing

Company

ELITE PHARMACEUTICALS INC /NV/

Filed

April 30, 2025

Period of Report

April 30, 2025

Accession Number

0001641172-25-007836

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →